Telehealth-Based Walking Program for Peripheral Arterial Disease
(TREK-PAD Trial)
Trial Summary
What is the purpose of this trial?
Walking is beneficial for adults with peripheral arterial disease. Benefits include the ability to walk for longer periods and general well being (quality of life). This study will look at two types of delivery methods for a home-based walking program. The walking program includes step count goals, information on healthy walking and motivational messages. The two delivery methods include a web-based delivery and an telehealth delivery. Participants are randomized to either one of the delivery methods or usual care. After 12 weeks participants in the web based or telehealth based groups maybe re-randomized to receive a combination of both web-based and telehealth for a second 12 week period. After 24 weeks, everyone is followed for an additional 12 weeks, so the total time a participant is in the study is 36 weeks. At baseline, 12, 24 and 36 weeks the investigators ask participant to walk (slowly) on a treadmill, perform a six-minute walk test, and several questionnaires on quality of life. Vouchers are provided at each study visit. All participants who complete the study also keep their pedometer.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team or your doctor.
What data supports the effectiveness of the treatment Telehealth-Based Walking Program for Peripheral Arterial Disease?
Is the Telehealth-Based Walking Program safe for humans?
How is the Telehealth-Based Walking Program for Peripheral Arterial Disease different from other treatments?
Research Team
Elizabeth A Jackson, MD
Principal Investigator
Birmingham VA Medical Center, Birmingham, AL
Eligibility Criteria
This trial is for men and women with lower extremity peripheral arterial disease (PAD) who experience claudication, can walk at least one block, have internet access, and do less than 150 minutes of physical activity per week. Excluded are those in nursing homes, with unstable heart conditions or recent cardiovascular events, planned surgeries, substance abuse issues, severe psychiatric disorders or comorbidities that severely limit walking.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline
Initial assessments and randomization to one of the study arms
Treatment Phase 1
Participants receive either web-based or telehealth delivered walking program or usual care
Treatment Phase 2
Non-responders are re-randomized to a combination of web-based and telehealth programs
Follow-up
Participants are monitored for longer-term responses and outcomes
Treatment Details
Interventions
- Walking Program (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Office of Research and Development
Lead Sponsor
Dr. Grant Huang
VA Office of Research and Development
Acting Chief Research and Development Officer
PhD in Medical Psychology and Master of Public Health from the Uniformed Services University of Health Sciences
Dr. Erica M. Scavella
VA Office of Research and Development
Chief Medical Officer since 2022
MD from University of Massachusetts School of Medicine